Lumakras 240 MG Oral Tablet
- RxCUI
- 2687207
- RxNorm name
- Lumakras 240 MG Oral Tablet
- Display name
- Lumakras 240 MG Oral Tablet
- Full name
- Lumakras 240 MG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LUMAKRAS | SOTORASIB | Amgen Inc | c80a362c-7ac3-4894-a076-0691e68ef8c1 | 2025-01-22 | Warnings, Adverse reactions | 2687207 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c80a362c-7ac3-4894-a076-0691e68ef8c1 | LUMAKRAS 240 MG Oral Tablet [PSN] · sotorasib 240 MG Oral Tablet [Lumakras] [SBD] · Lumakras 240 MG Oral Tablet [SY] | 3 | 19 | These highlights do not include all the information needed to use LUMAKRAS safely and effectively. See full prescribing information for LUMAKRAS. LUMAKRAS ® (sotorasib) tablets, for oral use Initial U.S. Approval: 2021 | 20250122 |